20 Oct 2023
|
DDT Performance section of the integrated ADS safety guidelines
|
ID-6
|
2023-10-20 |
20 Oct 2023
|
Matrix of DDT and User requirements with applicable test pillars
|
ID-6/Add.1
|
2023-10-20 |
23 Oct 2023
|
Audit section of the integrated ADS safety guidelines
|
ID-5
|
2023-10-23 |
1 Nov 2023
|
ID-1: Introduction section of the integrated ADS safety guidelines
|
ID-1
|
2023-11-01 |
1 Nov 2023
|
Scope and Purpose section of the integrated ADS safety guidelines
|
ID-2
|
2023-11-01 |
1 Nov 2023
|
Terms and Definitions section of the integrated ADS safety guidelines
|
ID-3
|
2023-11-01 |
1 Nov 2023
|
User Interactions section of the integrated ADS safety guidelines
|
ID-7
|
2023-11-01 |
2 Nov 2023
|
Overview of ADS safety guidelines
|
ID-4
|
2023-11-02 |
11 Nov 2023
|
In-Service Monitoring and Reporting
|
ID-8
|
2023-11-11 |
29 Nov 2023
|
Agenda for the first FRAV/VMAD joint session
|
FRAV-VMAD-01-01/Rev.1
|
2023-11-29 |
29 Nov 2023
|
FRAV/VMAD integrated document discussion table
|
FRAV-VMAD-01-02/Rev.3
|
2023-11-29 |
29 Nov 2023
|
Comments on the draft integrated FRAV/VMAD ADS guidelines (ETSC)
|
FRAV-VMAD-01-03
|
2023-11-29 |
29 Nov 2023
|
Comments on the draft integrated FRAV/VMAD ADS guidelines (CLEPA and OICA)
|
FRAV-VMAD-01-04
|
2023-11-29 |
29 Nov 2023
|
ADS safety: Input on definition of "safety-critical occurrence" (AAPC)
|
FRAV-VMAD-01-05
|
2023-11-29 |
29 Nov 2023
|
Comments on the draft integrated FRAV/VMAD ADS guidelines (UK)
|
FRAV-VMAD-01-07
|
2023-11-29 |
29 Nov 2023
|
ADS guidelines: Notes on cross-references and annexes in FRAV/VMAD integrated document (UK)
|
FRAV-VMAD-01-08
|
2023-11-29 |
11 Dec 2023
|
ADS guidelines: Proposal to amend "DDT fallback" definition (Netherlands and UK)
|
FRAV-VMAD-02-01
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Proposal for a "careful driving" amendment to overview section (ETSC)
|
FRAV-VMAD-02-02
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Proposal to amend "other road user" definition (Netherlands and UK)
|
FRAV-VMAD-02-03
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Input on definitional issues (SAE)
|
FRAV-VMAD-02-04/Rev.1
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Draft text, comments, and decisions from the 2nd FRAV/VMAD Integration session
|
FRAV-VMAD-02-05/Rev.1
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Draft annex on virtual/simulation testing
|
FRAV-VMAD-02-06
|
2023-12-11 |
11 Dec 2023
|
ADS guidelines: Proposal to update overview diagram (CLEPA and OICA)
|
FRAV-VMAD-02-07
|
2023-12-11 |
12 Dec 2023
|
ADS guidelines: Updated proposal for Overview diagram (CLEPA and OICA)
|
FRAV-VMAD-02-08/Rev.1
|
2023-12-12 |
12 Dec 2023
|
ADS guidelines: Comments and outcomes on audit and documentation provisions
|
FRAV-VMAD-02-09/Rev.1
|
2023-12-12 |
12 Dec 2023
|
ADS guidelines: Draft annex on approach for deriving verifiable DDT performance criteria
|
FRAV-VMAD-02-11
|
2023-12-12 |
12 Dec 2023
|
ADS guidelines: Outcomes and open points from discussions on integrated FRAV/VMAD draft
|
FRAV-VMAD-02-10/Rev.1
|
2023-12-12 |
15 Dec 2023
|
ADS guidelines: FRAV/VMAD next steps
|
FRAV-VMAD-02-12
|
2023-12-15 |